Methotrexate and nonsteroidal antiinflammatory drug interactions

Annals of Pharmacotherapy

Volumn 26, Issue 2, 1992, Pages 234-237

  Frenia, Maureen L ^a,b   Long, Kimberly S ^c   Hartshorn, Edward A ^d  

^a Kls Martin   (United States)

^b State University   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

7 HYDROXYMETHOTREXATE; ACETYLSALICYLIC ACID; DRUG METABOLITE; FLURBIPROFEN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTICLE; CASE REPORT; DRUG CLEARANCE; FEMALE; HUMAN; KIDNEY FAILURE; PANCYTOPENIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; BLOOD COMPONENT TRANSFUSION; CASE REPORT; DRUG INTERACTIONS; FEMALE; FLURBIPROFEN; FOLIC ACID; HOSPITALIZATION; HUMAN; METHOTREXATE; RANITIDINE; SUCRALFATE; VITAMIN K;

EID: 0026570125     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/106002809202600219     Document Type: Article

References (16)

1. Thyss A Milano G Kubar J Namer M Schneider M. Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen. Lancet 1986; 1: 256–8.
2. Daly HM Scott GL Boyle J Roberts CJC. Methotrexate toxicity precipitated by azapropazone. Br J Dermatol 1986; 114: 733–5.
3. Gabrielli A Leoni P Danieli G. Methotrexate and nonsteroidal antiinflammatory drugs (letter). Br Med J 1987; 294: 776.
4. Ellison NM Servi RJ. Acute renal failure and death following sequential intermediate-dose methotrexate and 5-FU: A possible adverse effect due to concomitant indomethacin administration. Cancer Treat Rep 1985; 69: 342–3.
5. Singh RR Malaviya AN Pandey JN Guleria JS. Fatal interaction between methotrexate and naproxen (letter). Lancet 1986; 1: 1390.
6. Maiche AG. Acute renal failure due to concomitant action of methotrexate and indomethacin (letter). Lancet 1986; 1: 1390.
7. Bloom EJ Ignoffo RJ Reis CA Cadman E. Delayed clearance of methotrexate associated with antibiotics and antiinflammatory agents (abstract). Clin Res 1986; 34: 560A.
8. Taylor JR Halprin KM. Effect of sodium salicylate and indomethacin on methotrexate-serum albumin binding. Arch Dermatol 1977; 113: 588–91.
9. Dettli L. Pharmacokinetic aspects of drug interactions. In: Cluff LE Petrie JC eds. Clinical effects of interactions between drugs. New York: Elsevier, 1974: 39–68.
10. Slordal L Sager G Aarbakke J. Pharmacokinetic interactions with methotrexate: Is 7-hydroxymethotrexate the culprit? (letter). Lancet 1988; 1: 591–2.
11. Furst DE Herman RA Koehnke R Ericksen N Hash L Riggs CE et al. Effect of aspirin and sulindac on methotrexate clearance. J Pharm Sci 1990; 79: 782–6.
12. Shen DD Azarnoff DL. Clinical pharmacokinetics of methotrexate. Clin Pharmacokinet 1978; 3: 1–13.
13. Ahern M Booth J Loxton A McCarthy P Meffin P Kevat S. Methotrexate kinetics in rheumatoid arthritis: Is there an interaction with nonsteroidal anti-inflammatory drugs? J Rheumatol 1988; 15: 1356–60.
14. Stewart CF Fleming RA Arkin CR Evans WE. Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis. Clin Pharmacol Ther 1990; 47: 540–6.
15. Skeith KJ Russell AS Jamali F Coates J Friedman H. Lack of significant interaction between low-dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis. J Rheumatol 1990; 17: 1008–10.
16. Dupuis LL Koren G Shore A Silverman ED Laxer RM. Methotrexate—nonsteroidal antiinflammatory drug interaction in children with arthritis. J Rheumatol 1990; 17: 1469–73.